Tesamorelin 20mg lyophilized research peptide vial
Tesamorelin 20mg

$115.00

Add to cart

Tesamorelin 20mg

$115.00

The larger 20mg Tesamorelin vial is specified for degradation series and parallel binding arms, where every sample must originate from the same lot for the comparison to hold.

Also available in 10mg

Tesamorelin 20mg Research Peptide

Tesamorelin 20mg is the larger presentation of a modified growth-hormone-releasing hormone analog engineered for resistance to enzymatic degradation. The compound matches the 10mg listing; this vial is specified for the scale of work rather than any difference in material.

Sized for parallel arms and long timelines

Stability research is the clearest case for the larger vial. Studies that track degradation across time points, temperatures or buffer conditions consume material steadily and depend absolutely on every sample originating from the same lot — a batch change partway through a degradation series undermines the entire comparison. The 20mg presentation covers that kind of design without interruption, at a lower cost per milligram than the smaller vial.

The same logic applies to parallel receptor-binding arms run against different reference ligands, where consistency of the test compound is what makes the comparison meaningful.

Research context

Tesamorelin is studied as a reference example of successful peptide stabilization: its N-terminal modification slows proteolytic breakdown while retaining GHRH receptor activity. Investigational areas include degradation kinetics, protease susceptibility profiling, receptor-binding assays, and comparative analysis against native GHRH fragments and against ghrelin-receptor secretagogues.

Specifications

  • Compound: Tesamorelin
  • Class: Stabilized GHRH analog
  • Label strength: 20mg
  • Best suited to: Parallel arms and extended stability studies
  • Intended use: Laboratory research only

Storage and handling

Store sealed, cool, dry and protected from light. Because stability work is a principal application of this compound, storage consistency is part of the experimental method and not merely good housekeeping. Retain full lot documentation for the duration of the study.

Supplied for research identification and catalog organization. No clinical, diagnostic, therapeutic or usage claims are made or implied.

Research Use Only: This product is sold strictly for laboratory research purposes. Not for human or veterinary use. Not for diagnostic, therapeutic, food, cosmetic, or household applications.

FDA Disclaimer: The statements on this website have not been evaluated by the U.S. Food and Drug Administration. The products and information provided by Vepra Peptides are not intended to diagnose, treat, cure, or prevent any disease.

Vepra Peptides is a research chemical supplier. We are not a compounding pharmacy or compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act, nor are we an outsourcing facility as defined under Section 503B.

All products are sold for research, laboratory, or analytical purposes only, and are NOT for human consumption. All sales are final. Customers are responsible for compliance with all applicable laws.